Sci-Tech News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.

Press releases published on October 1, 2026

Oct. 1, 2026

ReconAfrica Announces Appointment of Ryan Kubik as Independent Director

Indeterminate GlobeNewswire

Oct. 1, 2026

ESCO Completes Acquisition of Megger Group Limited

Indeterminate GlobeNewswire

Oct. 1, 2026

Elevra Lithium Provides Ewoyaa Sale Update

Indeterminate GlobeNewswire

Oct. 1, 2026

NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer

Indeterminate GlobeNewswire

Oct. 1, 2026

NANOBIOTIX annonce la nomination d’Arnd Christ au poste de directeur financier

Indeterminate GlobeNewswire

Oct. 1, 2026

ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering

Indeterminate GlobeNewswire

Oct. 1, 2026

WISeSat.Space Holdings Corp. Announces Closing of Business Combination with Columbus Acquisition Corp.

Indeterminate GlobeNewswire

Oct. 1, 2026

WISeKey’s Redomiciliation from Switzerland to the British Virgin Islands Becomes Legally Effective

Indeterminate GlobeNewswire

Oct. 1, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 1, 2026

Digital Realty Schedules Third Quarter 2026 Earnings Release and Conference Call

Indeterminate GlobeNewswire

Oct. 1, 2026

Liquidity Services Acquires Invaluable Marketplace

Indeterminate GlobeNewswire

Oct. 1, 2026

Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026

Indeterminate GlobeNewswire

Oct. 1, 2026

Healthy Moms, Healthy Babies America (HMHBA) Announces $20 Million in State Grants for Arkansas and Kentucky

Indeterminate GlobeNewswire

Oct. 1, 2026

Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel

Indeterminate GlobeNewswire

Oct. 1, 2026

Arvinas to Present Novel Biomarker Data from the Phase 1 Clinical Trial for ARV-102, a PROTAC LRRK2 Degrader, at the 2026 International Congress of Parkinson’s Disease and Movement Disorders®

Indeterminate GlobeNewswire

Oct. 1, 2026

Replimune Announces TUDRIQEV™ Now Available in the U.S. for Advanced Melanoma

Indeterminate GlobeNewswire

Oct. 1, 2026

New Canadian Centre for Space Isotopes Explores Canada’s Role Powering Future Space Missions

Indeterminate GlobeNewswire

Oct. 1, 2026

Recor Medical Announces AMA CPT Editorial Panel Approval of Two New Category I CPT® Codes for Renal Denervation

Indeterminate GlobeNewswire

Oct. 1, 2026

NexusTek Announces a New AI Strategy Assessment to Close the Gap Between AI Ideas and Actionable Investments

Indeterminate GlobeNewswire

Oct. 1, 2026

HOUSEHOLD DISINFECTANT MICROBAN 24 RETURNS TO MARKET WITH SAME 24-HOUR BACTERIA KILLING BENEFIT

Indeterminate GlobeNewswire